Datasheet
LQ089 is a tertiary-amine ionizable lipid reported in patent CN118506877A for mRNA lipid-nanoparticle research. In the cited luciferase-mRNA formulation, LQ089 LNPs showed higher whole-body reporter-expression exposure than the MC3 comparator after intravenous administration in mice. These preclinical results apply to the reported complete formulation and study conditions.
| Chemical Name | LQ089 |
| CAS No. | Not reported |
| Synonyms | LQ-089; LQ 089 |
| Formula | C43H83NO5 |
| M.Wt | 694.139 |
| SMILES | CCCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCN(CCO)CCCCCCCC(=O)OCC1CCCCC1 |
| Purity | Please confirm with sales |
| Storage | Please confirm with sales |
| Publication | Wang et al., Nature Communications 15, 10804 (2024). DOI:10.1038/s41467-024-55072-6; CN118506877A |
Research use only. DC Chemicals supplies the lipid only; literature LNP performance depends on the complete formulation and experimental conditions and is not guaranteed.